Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps
Executive Summary
Lilly unveiled a new discount program for its insulins, including Humalog, Humulin and Basaglar, that will reduce costs for people who pay full retail prices.
You may also be interested in...
Lowering Insulin Costs: Sanofi Seeks HHS Support For Expanding Assistance To Medicare Patients
HHS endorsement of company-sponsored discount programs for cash-paying customers with Medicare would be preferable to lowering list pricing.
Which Pharma Firm Increases US Prices The Most?
Transparency reports from companies aim to change conversation from prices to discounts, but also invite comparisons. Lilly, for example, saw a higher average list price increase in 2016 than Merck and Janssen, but its net prices grew by less than the others.
Which Pharma Firm Increases US Prices The Most?
Transparency reports from companies aim to change conversation from prices to discounts, but also invite comparisons. Lilly, for example, saw a higher average list price increase in 2016 than Merck and Janssen, but its net prices grew by less than the others.